WuXi AppTec Co., Ltd. (SHA:603259)

China flag China · Delayed Price · Currency is CNY
64.58
+2.93 (4.75%)
May 29, 2025, 2:42 PM CST
52.24%
Market Cap 176.16B
Revenue (ttm) 39.59B
Net Income (ttm) 11.18B
Shares Out 2.86B
EPS (ttm) 3.24
PE Ratio 16.31
Forward PE 14.27
Dividend 0.98 (1.58%)
Ex-Dividend Date May 21, 2025
Volume 38,955,619
Average Volume 34,742,579
Open 61.85
Previous Close 61.65
Day's Range 61.82 - 64.72
52-Week Range 36.36 - 70.68
Beta 0.84
RSI 56.07
Earnings Date Jul 27, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ... [Read more]

Sector Healthcare
Founded 2000
Employees 39,414
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603259
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial Statements

News

There is no news available yet.